A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
This study aims to identify how useful polygenic and integrated risk is in both helping doctors to treat and manage their patients, and identifying people at risk of developing coronary artery disease. Targeted population is previously genotyped individuals in the PMBB. We will calculate an integrated risk score for coronary …
Our goal is to identify markers which can predict response to therapy in patients with dermatomyositis, systemic sclerosis, lupus erythematosus, morphea, eosinophilic fasciitis, and other immune-mediated cutaneous and rheumatic diseases. To collect human tissue from lesional and non-lesional skin, as well as blood, cheek swabs, photographs of biopsy site(s) or …
This research study is being done to learn about certain characteristics of the skin and how these characteristics are related to the severity of atopic dermatitis (AD) and the skins response to treatment. Subjects 18 and older diagnosed with AD and Non Ad subjects.Procedures include vital signs, pregnancy status (if …
Multi-arm, multi-center, open label, prospective observational registry designed to obtain safety and performance data on the use of CE marked and custom Terumo Aortic endovascular grafts.
Join the largest, long-term nationwide study that hopes to better understand baby brain development. Leading researchers in the fields of child development and neuroscience will work with participating families and their children to understand how the brain develops and is affected by exposure to substances and other environmental, social, and …
Patients with an epiretinal membrane (ERM) are either referred for vitrectomy, or if their vision is normal are deferred until vision declines. It is unknown if delaying surgery results in worse visual acuity than if surgery is performed earlier. Additionally, a common symptom from an ERM is metamorphopsia. The objective …
To assess the effect of nintedanib on preserving L-PF measured symptom levels (cough, dyspnea, energy), impacts of disease, and quality of life in patients with MA-ILD who are also receiving SOC treatment.